(Reuters) -Hedge fund Starboard Value has taken a stake in Kenvue, the consumer products company that makes Band-Aid, ...
Activist investor Starboard Value is baring its teeth at Pfizer management, more openly going after CEO Albert Bourla’s job.
Corvex Management LP has taken a stake in Fortrea Holdings Inc., a clinical trials management company that was spun out of ...
Adds Kenvue comment. Kenvue (NYSE:KVUE) needs to focus on fixing its skin, health and beauty segments, Jeff Smith, founder ...
Activist investor Starboard Value reportedly has taken a large stake in consumer health products maker Kenvue.
Starboard Chief Executive Jeff Smith said that Kenvue, the Tylenol-maker spun out from Johnson & Johnson, should drill down on fixing its underperforming skin health and beauty segment, which he ...
Activist investor Starboard Value, which picked up a $1 billion stake in Pfizer earlier this month, now reportedly has ...
Starboard Value contends that Kenvue, with strong consumer health brands like Tylenol and Listerine, is underperforming its ...
The growth rate of the consumer healthcare business could accelerate now that an activist investor is involved.
As the Murdochs take their succession battle to court, industry insiders warn the end of the dynasty may be in sight.
Despite that cash windfall, Pfizer has "dramatically underperformed its peers and the market since 2019," according to ...